Portal vein thrombosis in cirrhosis

Journal of Clinical and Experimental Hepatology

Volumn 4, Issue 4, 2014, Pages 320-331

  Raja, Kaiser ^a   Jacob, Mathew ^a   Asthana, Sonal ^a  

^a BGS Global Hospital   (India)

Author keywords

Anticoagulation; Cirrhosis; Portal vein thrombosis; Portocaval hemitransposition

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ANTICOAGULANT THERAPY; BLEEDING; BLOOD CLOTTING; DIAGNOSTIC ACCURACY; DISEASE COURSE; DISEASE EXACERBATION; ECHOGRAPHY; END TO END ANASTOMOSIS; GASTROINTESTINAL HEMORRHAGE; HUMAN; HYPERCOAGULABILITY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FAILURE; LIVER TRANSPLANTATION; PATHOPHYSIOLOGY; PORTAL VEIN; PORTAL VEIN BLOOD FLOW; PORTAL VEIN BLOOD PRESSURE; PORTAL VEIN THROMBOSIS; PREVALENCE; REVIEW; SPLENIC VEIN; SUPERIOR MESENTERIC VEIN; THROMBECTOMY; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; TREATMENT CONTRAINDICATION; VASCULAR PATENCY; VEIN STRIPPING;

EID: 84920808423     PISSN: 09736883     EISSN: 22133453     Source Type: Journal    
DOI: 10.1016/j.jceh.2013.12.003     Document Type: Review

References (87)

1. Englesbe M.J., Kubus J., Muhammad W., et al. Portal vein thrombosis and survival in patients with cirrhosis. Liver Transpl 2010, 16:83-90.
2. Okuda K., Ohnishi K., Kimura K., et al. Incidence of portal vein thrombosis in liver cirrhosis. An angiographic study in 708 patients. Gastroenterology 1985, 89:279-286.
3. Francoz C., Belghiti J., Vilgrain V., et al. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut 2005, 54:691-697.
4. Llado L., Fabregat J., Castellote J., et al. Management of portal vein thrombosis in liver transplantation: influence on morbidity and mortality. Clin Transplant 2007, 21:716-721.
5. Manzanet G., Sanjuan F., Orbis P., et al. Liver transplantation in patients with portal vein thrombosis. Liver Transpl 2001, 7:125-131.
6. Yerdel M.A., Gunson B., Mirza D., et al. Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome. Transplantation 2000, 69:1873-1881.
7. Gayowski T.J., Marino I.R., Doyle H.R., et al. Ahigh incidence of native portal vein thrombosis in veterans undergoing liver transplantation. JSurg Res 1996, 60:333-338.
8. Amitrano L., Brancaccio V., Guardascione M.A., et al. Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis. Hepatology 2000, 31:345-348.
9. Maruyama H., Okugawa H., Takahashi M., Yokosuka O. De novo portal vein thrombosis in virus-related cirrhosis: predictive factors and long-term outcomes. Am J Gastroenterol 2013, 108:568-574.
10. Fimognari F.L., De Santis A., Piccheri C., et al. Evaluation of D-dimer and factor VIII in cirrhotic patients with asymptomatic portal venous thrombosis. JLab Clin Med 2005, 146:238-243.
11. Gaiani S., Bolondi L., Li Bassi S., Zironi G., Siringo S., Barbara L. Prevalence of spontaneous hepatofugal portal flow in liver cirrhosis. Clinical and endoscopic correlation in 228 patients. Gastroenterology 1991, 100:160-167.
12. Amitrano L., Guardascione M.A., Brancaccio V., et al. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. JHepatol 2004, 40:736-741.
13. Dumortier J., Czyglik O., Poncet G., et al. Eversion thrombectomy for portal vein thrombosis during liver transplantation. Am J Transplant 2002, 2:934-938.
14. Arjal R., Trotter J.F. International normalized ratio of prothrombin time in the model for end-stage liver disease score: an unreliable measure. Clin Liver Dis 2009, 13:67-71.
15. Monroe D.M., Hoffman M. The coagulation cascade in cirrhosis. Clin Liver Dis 2009, 13:1-9.
16. Tripodi A., Primignani M., Chantarangkul V., et al. An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis. Gastroenterology 2009, 137:2105-2111.
17. Jennings I., Calne R.Y., Baglin T.P. Predictive value of von Willebrand factor to ristocetin cofactor ratio and thrombin-antithrombin complex levels for hepatic vessel thrombosis and graft rejection after liver transplantation. Transplantation 1994, 57:1046-1051.
18. De Caterina M., Tarantino G., Farina C., et al. Haemostasis unbalance in Pugh scored liver cirrhosis: characteristic changes of plasma levels of protein C versus protein S. Haemostasis 1993, 23:229-235.
19. Raya-Sanchez J.M., Gonzalez-Reimers E., Rodriguez-Martin J.M., et al. Coagulation inhibitors in alcoholic liver cirrhosis. Alcohol 1998, 15:19-23.
20. Tripodi A., Salerno F., Chantarangkul V., et al. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology 2005, 41:553-558.
21. Oliver J.A., Monroe D.M., Church F.C., et al. Activated protein C cleaves factor Va more efficiently on endothelium than on platelet surfaces. Blood 2002, 100:539-546.
22. Violi F., Ferro D., Basili S., et al. Association between low-grade disseminated intravascular coagulation and endotoxemia in patients with liver cirrhosis. Gastroenterology 1995, 109:531-539.
23. Tripodi A., Primignani M., Chantarangkul V., et al. Thrombin generation in patients with cirrhosis: the role of platelets. Hepatology 2006, 44:440-445.
24. Lisman T., Bongers T.N., Adelmeijer J., et al. Elevated levels of von Willebrand factor in cirrhosis support platelet adhesion despite reduced functional capacity. Hepatology 2006, 44:53-61.
25. Gulley D., Teal E., Suvannasankha A., Chalasani N., Liangpunsakul S. Deep vein thrombosis and pulmonary embolism in cirrhosis patients. Dig Dis Sci 2008, 53:3012-3017.
26. Northup P.G., McMahon M.M., Ruhl A.P., et al. Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism. Am J Gastroenterol 2006, 101:1524-1528.
27. Garcia-Fuster M.J., Abdilla N., Fabia M.J., Fernandez C., Oliver V., Forner M.J. Venous thromboembolism and liver cirrhosis. Rev Esp Enferm Dig 2008, 100:259-262.
28. Martinelli I., Primignani M., Aghemo A., et al. High levels of factor VIII and risk of extra-hepatic portal vein obstruction. JHepatol 2009, 50:916-922.
29. DeLeve L.D., Valla D.C., Garcia-Tsao G. Vascular disorders of the liver. Hepatology 2009, 49:1729-1764.
30. Shah V. Molecular mechanisms of increased intrahepatic resistance in portal hypertension. JClin Gastroenterol 2007, 41:S259-S261.
31. Zocco M.A., Di Stasio E., De Cristofaro R., et al. Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development. JHepatol 2009, 51:682-689.
32. Lisman T., Porte R.J. The role of platelets in liver inflammation and regeneration. Semin Thromb Hemost 2010, 36:170-174.
33. Mangia A., Villani M.R., Cappucci G., et al. Causes of portal venous thrombosis in cirrhotic patients: the role of genetic and acquired factors. Eur J Gastroenterol Hepatol 2005, 17:745-751.
34. Violi F., Ferro D., Basili S., et al. Ongoing prothrombotic state in the portal circulation of cirrhotic patients. Thromb Haemost 1997, 77:44-47.
35. Lin R.S., Lee F.Y., Lee S.D., et al. Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation. JHepatol 1995, 22:165-172.
36. Lumsden A.B., Henderson J.M., Kutner M.H. Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis. Hepatology 1988, 8:232-236.
37. Amitrano L., Brancaccio V., Guardascione M.A., et al. Portal vein thrombosis after variceal endoscopic sclerotherapy in cirrhotic patients: role of genetic thrombophilia. Endoscopy 2002, 34:535-538.
38. Politoske D., Ralls P., Korula J. Portal vein thrombosis following endoscopic variceal sclerotherapy. Prospective controlled comparison in patients with cirrhosis. Dig Dis Sci 1996, 41:185-190.
39. Shim C.S., Cho Y.D., Kim J.O., et al. Acase of portal and splenic vein thrombosis after histoacryl injection therapy in gastric varices. Endoscopy 1996, 28:461.
40. Tripodi A. Tests of coagulation in liver disease. Clin Liver Dis 2009, 13:55-61.
41. Hemker H.C., Giesen P., Al Dieri R., et al. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 2003, 33:4-15.
42. Chantarangkul V., Clerici M., Bressi A., et al. Thrombin generation assessed as endogenous thrombin potential (ETP) in patients with hypo- or hyper-coagulability. Effects of phospholipids, tissue factor and residual platelets on the measurement performed in platelet-poor and platelet-rich plasma. Haematologica 2003, 88:547-554.
43. Koh M.B., Hunt B.J. The management of perioperative bleeding. Blood Rev 2003, 17:179-185.
44. D'Amico G., De F.R. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology 2003, 38:599-612.
45. Englesbe M.J., Schaubel D.E., Cai S., Guidinger M.K., Merion R.M. Portal vein thrombosis and liver transplant survival benefit. Liver Transpl 2010, 16:999-1005.
46. Ferreira C.N., Rodrigues T., Alexandrino P., Ramalho F., Velosa J.F. Portal vein thrombosis in cirrhotic patients is associated with advanced liver disease and predicts poor long-term prognosis. Hepatology 2010, 52:1072A.
47. Francoz C., Valla D., Francois D. Portal vein thrombosis, cirrhosis, and liver transplantation. JHepatol 2012, 57:203-212.
48. Piscaglia F., Gianstefani A., Ravaioli M., et al. Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation. Liver Transpl 2010, 16:658-667.
49. Tublin M.E., Dodd G.D., Baron R.L. Benign and malignant portal vein thrombosis: differentiation by CT characteristics. AJR Am J Roentgenol 1997, 168:719-723.
50. Song Z.Z., Huang M., Jiang T.A., et al. Diagnosis of portal vein thrombosis discontinued with liver tumors in patients with liver cirrhosis and tumors by contrast-enhanced US: a pilot study. Eur J Radiol 2010, 75:185-188.
51. Wallner B., Edelman R.R., Finn J.P., Mattle H.P. Bright pleural effusion and ascites on gradient-echo MR images: a potential source of confusion in vascular MR studies. AJR Am J Roentgenol 1990, 155:1237-1240.
52. Senzolo M., Sartori M., Rossetto V., et al. Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis. Liver Int 2012, 32:919-927.
53. De S.A., Moscatelli R., Catalano C., et al. Systemic thrombolysis of portal vein thrombosis in cirrhotic patients: a pilot study. Dig Liver Dis 2010, 42:451-455.
54. Ravaioli M., Zanello M., Grazi G.L., et al. Portal vein thrombosis and liver transplantation: evolution during 10 years of experience at the University of Bologna. Ann Surg 2011, 253:378-384.
55. Shi L.W., Verran D., Chang D., et al. Primary liver transplantation with preexisting portal vein thrombosis. Transplant Proc 2003, 35:354-355.
56. Doenecke A., Tsui T.Y., Zuelke C., et al. Pre-existent portal vein thrombosis in liver transplantation: influence of preoperative disease severity. Clin Transplant 2010, 24:48-55.
57. Bertelli R., Nardo B., Montalti R., et al. Liver transplantation in recipients with portal vein thrombosis: experience of a single transplant center. Transplant Proc 2005, 37:1119-1121.
58. Delgado M.G., Seijo S., Yepes I., et al. Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis. Clin Gastroenterol Hepatol 2012, 10:776-783.
59. Huard G., Bilodeau M. Management of anticoagulation for portal vein thrombosis in individuals with cirrhosis: a systematic review. Int J Hepatol 2012, 2012:672986.
60. Amitrano L., Guardascione M.A., Menchise A., et al. Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis. JClin Gastroenterol 2010, 44:448-451.
61. Bechmann L.P., Sichau M., Wichert M., Gerken G., Kroger K., Hilgard P. Low-molecular-weight heparin in patients with advanced cirrhosis. Liver Int 2011, 31:75-82.
62. Tripodi A., Anstee Q.M., Sogaard K.K., et al. Hypercoagulability in cirrhosis: causes and consequences. JThromb Haemost 2011, 9:1715-1723.
63. Valla D.C. Thrombosis and anticoagulation in liver disease. Hepatology 2008, 47:1384-1393.
64. Tripodi A., Mannucci P.M. The coagulopathy of chronic liver disease. NEngl J Med 2011, 365:147-156.
65. Lisman T., Kamphuisen P.W., Northup P.G., Porte R.J. Established and new-generation antithrombotic drugs in patients with cirrhosis - possibilities and caveats. JHepatol 2013, 59:358-366.
66. Han G., Qi X., He C., et al. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis. JHepatol 2011, 54:78-88.
67. Perarnau J.M., Baju A., D'Alteroche L., Viguier J., Ayoub J. Feasibility and longterm evolution of TIPS in cirrhotic patients with portal thrombosis. Eur J Gastroenterol Hepatol 2010, 22:1093-1098.
68. Senzolo M., Burra P., Patch D., Burroughs A.K. Tips for portal vein thrombosis in cirrhosis: not only unblocking a pipe. JHepatol 2011, 55:945-946.
69. Senzolo M., Tibbals J., Cholongitas E., Triantos C.K., Burroughs A.K., Patch D. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation. Aliment Pharmacol Ther 2006, 23:767-775.
70. Luca A., Miraglia R., Caruso S., et al. Short and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis. Gut 2011, 60:846-852.
71. Ferral H., Gamboa P., Postoak D.W., et al. Survival after elective transjugular intrahepatic portosystemic shunt creation: prediction with model for end-stage liver disease score. Radiology 2004, 231:231-236.
72. Hollingshead M., Burke C.T., Mauro M.A., Weeks S.M., Dixon R.G., Jaques P.F. Transcatheter thrombolytic therapy for acute mesenteric and portal vein thrombosis. JVasc Interv Radiol 2005, 16:651-661.
73. Villa E., Zecchini R., Marietta M., et al. Enoxaparin prevents portal vein thrombosis and decompensation in advanced cirrhotic patients: final report of a prospective randomized controlled study. Hepatology 2011, 54:418A-419A.
74. Nevens F., Bustami R., Scheys I., Lesaffre E., Fevery J. Variceal pressure is a factor predicting the risk of a first variceal bleeding: a prospective cohort study in cirrhotic patients. Hepatology 1998, 27:15-19.
75. Tsochatzis E.A., Senzolo M., Germani G., Gatt A., Burroughs A.K. Systematic review: portal vein thrombosis in cirrhosis. Aliment Pharmacol Ther 2010, 31:366-374.
76. Garcia-Tsao G., Sanyal A.J., Grace N.D., et al. AASLD practice guidelines: prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology 2007, 46:922-938.
77. Van Thiel D.H., Schade R.R., Starzl T.E., et al. Liver transplantation in adults. Hepatology 1982, 2:637-640.
78. Shaw B.W., Iwatsuki S., Bron K., Starzl T.E. Portal vein grafts in hepatic transplantation. Surg Gynecol Obstet 1985, 161:66-68.
79. Ponziani F.R., Zocco M.A., Campanale C., et al. Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment. World J Gastroenterol 2010, 16:143-155.
80. Wu T.H., Lin Y.S., Lee C.F., et al. Clinical analysis and strategy for liver transplantation in patients with pre-existing portal vein thrombosis. Chang Gung Med J 2011, 34:426-434.
81. Rodriguez-Castro K.I., Porte R.J., Nadal E., Germani G., Burra P., Senzolo M. Management of nonneoplastic portal vein thrombosis in the setting of liver transplantation: a systematic review. Transplantation 2012, 94:1145-1153.
82. Paskonis M., Jurgaitis J., Mehrabi A., et al. Surgical strategies for liver transplantation in the case of portal vein thrombosis - current role of cavoportal hemitransposition and renoportal anastomosis. Clin Transplant 2006, 20:551-562.
83. Lendoire J., Raffin G., Cejas N., et al. Liver transplantation in adult patients with portal vein thrombosis: risk factors, management and outcome. HPB (Oxford) 2007, 9:352-356.
84. Gimeno F.A., Calvo J., Loinaz C., et al. Comparative analysis of the results of orthotopic liver transplantation in patients with and without portal vein thrombosis. Transplant Proc 2005, 37:3899-3903.
85. Ceulemans B., Aerts R., Monbaliu D., et al. Liver transplantation using cavoportal transposition: an effective treatment in patients with complete splanchnic venous thrombosis. Transplant Proc 2005, 37:1112.
86. Urbani L., Cioni R., Catalano G., et al. Cavoportal hemitransposition: patient selection criteria and outcome. Transplant Proc 2002, 34:3331.
87. Arcadipane A., Nadalin S., Gruttadauria S., et al. The recipient with portal thrombosis and/or previous surgery. Transplant Proc 2008, 40:1183-1186.